2 vials Save $66.25

KLOW Blend 80mg

4-component research blend

$212.49

NAD+ 500mg

Dinucleotide coenzyme

$118.74

Research bundle · 2 vials

KLOW Blend 80mg + NAD+ 500mg Research Bundle

USA Made, ≥99% Purity Per Compound

Separate retail vials: KLOW Blend 80mg (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg); NAD+ 500mg
USA manufactured in a Certified GMP California and Arizona laboratory.
≥99% purity target per compound with third-party HPLC, mass spectrometry, and batch-specific COAs

Combined retail value$331.23

Bundle saving−$66.25

$264.98 $331.23 Save $66.25

Each vial ships in its original retail format with its own batch COA

Dispatched from a US warehouse within 48 hours, tracked

Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Per-compound specifications

2 vials

Nothing in this bundle is co-formulated. Each vial keeps its own identity, purity target, and certificate, and is specified separately below.

Vial 01

KLOW Blend 80mg

Sequences

GHK-Cu: GHK·Cu²⁺; BPC-157: GEPPPGKPADDAGLV; TB-500: Ac-LKKTETQ; KPV: Lys-Pro-Val

CAS: GHK-Cu: 89030-95-5; BPC-157: 137525-51-0; TB-500: 885340-08-9; KPV: 67727-97-3
Molecular mass: GHK-Cu: 402.92; BPC-157: 1,419.5; TB-500: 889.01; KPV: 342.43 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 02

NAD+ 500mg

Structure

N/A — NAD+ is a dinucleotide coenzyme, not a peptide

CAS: 53-84-9
Molecular mass: 663.43 g/mol (anhydrous free-acid basis)
Purity target: ≥99%
Form: Lyophilized Powder

Form: 2 Separate Lyophilized Powders
Purity target: ≥99% per compound (3rd-Party HPLC Tested)
Origin: All Included Products: Synthesized, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is the KLOW Blend and NAD+ Research Bundle?

This two-vial bundle pairs KLOW Blend 80mg with NAD+ 500mg. KLOW contains GHK-Cu 50mg plus BPC-157 10mg, TB-500 10mg, and KPV 10mg; NAD+ is a separate non-peptide coenzyme used in redox and enzyme-signaling research.

The bundle spans copper coordination, matrix, vascular, cytoskeletal, inflammatory, and cellular energy pathways while preserving the original retail formats. NAD+ is not mixed into KLOW, and no combined clinical effect is claimed.

How It Works

GHK-Cu supports copper and matrix research: Models examine copper coordination, fibroblast activity, and extracellular-matrix remodeling.

BPC-157, TB-500, and KPV add distinct signals: Research spans vascular and migration pathways, an actin-binding motif, peptide transport, and inflammatory responses.

NAD+ supports redox and enzyme research: It carries electrons and serves as a consumed substrate for sirtuins, PARPs, CD38, and related enzymes.

Analytical data

One certificate per vial

Independent third-party HPLC assesses each compound against its ≥99% purity target, while mass spectrometry confirms identity. For each vial, the results are documented in one combined, batch-specific COA report.

Lot: KL-59812
Reported: 2026-05-12
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.52%
Net content: 80.56 mg
Appearance: White lyophilized powder

Download COA

Lot: NA-75688
Reported: 2026-05-12
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.64%
Net content: 502.00 mg
Appearance: White lyophilized powder

Download COA

Why Source from 321 Peptides?

Domestic accountability.

All included compounds are synthesized, manufactured, and finished in Certified GMP California and Arizona laboratory facilities—never sourced from overseas or Mexico. That means direct domestic supply-chain accountability from production through fulfillment.

Verification you can inspect.

Protected in transit.

Every included product is freeze-dried to help preserve stability during storage and shipping. Rapid domestic fulfillment reduces unnecessary time and handling.

Lot history 8 released lots

Every batch released under each vial in this bundle, with the figure reported for each. Vials are shipped from current stock.

Compound	Lot	Reported	Purity	Net content	COA
KLOW Blend 80mg	KLO432	2026-06-01	99.78%	GHK-Cu - 55.24 mg, KPV - 10.78 mg, BPC-157 - 10.24 mg, Thymosin Beta-4 - 10.58 mg	PDF
	KL-59812	2026-05-12	99.52%	80.56 mg	Pending
	KL-58658	2026-05-06	99.88%	80.40 mg	Pending
	KL-59235	2026-05-02	99.71%	80.48 mg	Pending
NAD+ 500mg	NA430	2026-06-01	99.83%	535.51 mg	PDF
	NA-75688	2026-05-12	99.64%	502.00 mg	Pending
	NA-76265	2026-04-30	99.88%	502.50 mg	Pending
	NA-76842	2026-02-25	99.71%	503.00 mg	Pending

Frequently Asked Questions

What comes in the KLOW Blend and NAD+ bundle?

The bundle includes KLOW Blend 80mg (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg); NAD+ 500mg. Each retail product arrives in its original lyophilized vial with batch-specific COA documentation.

What research pathways are represented in the KLOW and NAD+ bundle?

KLOW combines copper/matrix, vascular, cytoskeletal, and inflammatory-signaling research components. NAD+ adds a separate coenzyme for redox, energy-metabolism, and NAD+-consuming enzyme studies.